• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    NeurogesX, Inc. (NGSX)

    -Other OTC
    0.00 Down 0.00(38.00%) Dec 19, 1:48PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2012Jun 30, 2012Mar 31, 2012Dec 31, 2011
    Total Revenue 2,834   3,057   2,973   2,958  
    Cost of Revenue72  94  681  151  
    Gross Profit 2,762   2,963   2,292   2,807  
    Operating Expenses
    Research Development1,326  1,539  2,933  2,412  
    Selling General and Administrative2,776  3,424  7,263  7,537  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (1,340) (2,000) (7,904) (7,142)
    Income from Continuing Operations
    Total Other Income/Expenses Net -  (5)(48)8  
    Earnings Before Interest And Taxes(1,340)(2,005)(7,952)(7,134)
    Interest Expense2,475  3,468  3,220  3,107  
    Income Before Tax(3,815)(5,473)(11,172)(10,241)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(3,815)(5,473)(11,172)(10,241)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (3,815) (5,473) (11,172) (10,241)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (3,815) (5,473) (11,172) (10,241)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.